Literature DB >> 9743304

Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade.

P Kronqvist1, T Kuopio, Y Collan.   

Abstract

We analysed 170 histological samples of invasive ductal breast cancer from years 1988-91 by computerized nuclear morphometry, to find objective and quantitative thresholds for nuclear grade. Based on Kaplan-Meier curves reflecting survival and recurrence of disease and univariate analysis by Cox's regression, optimal thresholds were determined for features related to nuclear size and size variation. In our material, with mean follow-up time of 5 years 9 months, the determined thresholds for nuclear profile area (32 microm2 and 47 microm2), nuclear diameter (6.4 microm and 7.4 microm) and mean shortest nuclear axis (4.8 microm and 6.4 microm) best separated the cases with favourable, intermediate and unfavourable course of disease. In this material from the era of mammography and adjuvant therapy, the mean shortest nuclear axis was found to be a significant prognostic factor, with a risk ratio (RR) exceeded only by that of tumour size (RRs 2.9- and 3.5-fold respectively). The results suggest that morphometric grading criteria can be developed for application in Bloom-Richardson grading and in the Nottingham Prognostic Index.

Entities:  

Mesh:

Year:  1998        PMID: 9743304      PMCID: PMC2062958          DOI: 10.1038/bjc.1998.582

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer.

Authors:  M Stierer; H Rosen; R Weber
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

Review 2.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Authors:  M H Zweig; G Campbell
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

3.  Prognostic value of morphometry and DNA flow-cytometry features of invasive breast cancers detected by population screening: comparison with control group of hospital patients.

Authors:  A M Uyterlinde; J P Baak; N W Schipper; H J Peterse; J W Meijer; P G Vooys; E Matze
Journal:  Int J Cancer       Date:  1991-05-10       Impact factor: 7.396

4.  Prognostic indicators in breast cancer--morphometric methods.

Authors:  J P Baak; P H Kurver; A J De Snoo-Niewlaat; S De Graef; B Makkink; M E Boon
Journal:  Histopathology       Date:  1982-05       Impact factor: 5.087

5.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

6.  Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.

Authors:  H F Frierson; R A Wolber; K W Berean; D W Franquemont; M J Gaffey; J C Boyd; D C Wilbur
Journal:  Am J Clin Pathol       Date:  1995-02       Impact factor: 2.493

7.  Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index.

Authors:  D E Henson; L Ries; L S Freedman; M Carriaga
Journal:  Cancer       Date:  1991-11-15       Impact factor: 6.860

8.  Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer.

Authors:  S Aaltomaa; P Lipponen; M Eskelinen; V M Kosma; S Marin; E Alhava; K Syrjänen
Journal:  Am J Surg       Date:  1993-03       Impact factor: 2.565

Review 9.  Adjuvant therapy in breast cancer.

Authors:  N J Robert
Journal:  Obstet Gynecol Clin North Am       Date:  1994-12       Impact factor: 2.844

10.  Histological grading of breast carcinomas: a study of interobserver agreement.

Authors:  P Robbins; S Pinder; N de Klerk; H Dawkins; J Harvey; G Sterrett; I Ellis; C Elston
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

View more
  13 in total

1.  Nuclear morphometry in columnar cell lesions of the breast: is it useful?

Authors:  C N Lim; B C S Ho; B H Bay; G Yip; P H Tan
Journal:  J Clin Pathol       Date:  2006-04-07       Impact factor: 3.411

2.  Disease-on-a-chip: mimicry of tumor growth in mammary ducts.

Authors:  Pierre-Alexandre Vidi; Teimour Maleki; Manuel Ochoa; Lei Wang; Sara M Clark; James F Leary; Sophie A Lelièvre
Journal:  Lab Chip       Date:  2013-11-08       Impact factor: 6.799

3.  [Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker].

Authors:  R von Wasielewski; K Klöpper; H J Lück; H Kreipe
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

Review 4.  [Histological grading of breast cancer].

Authors:  M Christgen; F Länger; H Kreipe
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

5.  Isotropic 3D nuclear morphometry of normal, fibrocystic and malignant breast epithelial cells reveals new structural alterations.

Authors:  Vivek Nandakumar; Laimonas Kelbauskas; Kathryn F Hernandez; Kelly M Lintecum; Patti Senechal; Kimberly J Bussey; Paul C W Davies; Roger H Johnson; Deirdre R Meldrum
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

6.  Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?

Authors:  A Elzagheid; T Kuopio; S Pyrhönen; Y Collan
Journal:  Diagn Pathol       Date:  2006-11-08       Impact factor: 2.644

7.  Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer.

Authors:  Yan Cui; Esther A Koop; Paul J van Diest; Rita A Kandel; Thomas E Rohan
Journal:  Breast Cancer Res Treat       Date:  2006-10-24       Impact factor: 4.872

8.  Morphometric grading of breast cancer: thresholds for tubular differentiation.

Authors:  P Kronqvist; T Kuopio; Y Collan
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

9.  High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients.

Authors:  G-B Qiao; Y-L Wu; X-N Yang; W-Z Zhong; D Xie; X-Y Guan; D Fischer; H-C Kolberg; S Kruger; H-W Stuerzbecher
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

10.  Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer.

Authors:  P Kronqvist; T Kuopio; P Jalava; Y Collan
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.